News

February 23, 2018February 23, 2018

IRF5 Gene Variation May Be Risk Factor for Juvenile Arthritis, Study Suggests

News

A new study revealed that a variation in the gene of interferon regulatory factor 5 (IRF5) — a factor involved in cell growth, cell differentiation, and immune system activation — ... Read more

February 19, 2018February 19, 2018

Specific Autoantibodies More Prevalent in Juvenile Arthritis Patients

News

Specific types of autoantibodies are more prevalent in children with juvenile arthritis and juvenile myositis than in healthy children, and is linked to more severe disease in myositis patients. The study, ... Read more

February 16, 2018February 16, 2018

American College of Rheumatology Drops Its Early Caution, Supports Biosimilars

News

The American College of Rheumatology has issued a white paper supporting the use of biosimilars as treatments for rheumatic diseases. It had urged caution when the first biosimilars for these disorders ... Read more

February 14, 2018February 14, 2018

Protein Levels in Blood May Help Determine Treatment Intensity in Early Rheumatoid Arthritis

News

Single variants in a specific gene and how they correlate with peptide levels in the blood may help predict treatment requirements in early rheumatoid arthritis. The study, “Vasoactive intestinal peptide ... Read more

February 12, 2018February 12, 2018

US Demand for Rheumatologists Will Outstrip Supply by 2030, Studies Show

News

U.S. demand for rheumatologists will greatly surpass the projected growth of the rheumatology workforce over the next 12 years, two studies show. Overall, the studies point to an increasingly aging ... Read more

February 9, 2018February 9, 2018

Women With JIA Experience Highest Disease Activity 6 Weeks After Giving Birth

News

A recent study has investigated juvenile idiopathic arthritis disease activity in women before, during and after pregnancy, a topic about which there is little knowledge. The results revealed that at ... Read more

February 7, 2018February 7, 2018

Abnormal Expansion of Specific Type of Immune Cell Associated with Juvenile Arthritis

News

High levels of switched memory B-cells (SwM B-cells), a subtype of white blood cells, are associated with oligoarticular and polyarticular juvenile idiopathic arthritis (JIA), according to a recent study. These ... Read more

February 5, 2018February 5, 2018

Specific Blood Protein May Help Predict Response to Juvenile Arthritis Treatment

News

Measuring the levels of a specific protein in the blood before starting treatment with disease-modifying anti-rheumatic drugs may help predict patients’ response to therapy, according to a recent study published ... Read more

January 31, 2018January 31, 2018

Weekly Doses of Adalimumab Are Safe for Juvenile Arthritis and Uveitis Patients, Study Shows

News

Weekly doses of adalimumab are a safe treatment for juvenile arthritis patients or children with chronic eye inflammation, a study reports. Adalimumab, sold as Humira and under other brand names, is ... Read more

January 26, 2018January 26, 2018

Parents Concerned About Treatment Side Effects, Safety in Children with Juvenile Idiopathic Arthritis, Study Finds

News

A treatment’s long-term safety and the impact of its side effects on quality of life are the top concerns of parents with children who have juvenile idiopathic arthritis (JIA), a new ... Read more